Williams Lewis T
SEC insider (Form 3/4/5 filer). CIK 0001475714. Director at Protagonist Therapeutics, Inc (PTGX). 4 reported Form 4/5 transactions since Sep 2024; latest on Feb 17, 2026. Located in NEWARK, CA.
Companies Williams Lewis T has filed insider reports for
- Protagonist Therapeutics, Inc (PTGX): Director
Williams Lewis T
CIK: 0001475714
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (25.0%)
Position reduction
Option Exercises (M)1 (25.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PTGX
Protagonist Therapeutics, Inc
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Feb 17, 2026PTGX
Protagonist Therapeutics, Inc
ExerciseDirect18K shares at avg. $10.84$195K - Feb 17, 2026PTGX
Protagonist Therapeutics, Inc
SaleDirect18K shares at avg. $82.42$1.5M - Jan 2, 2026PTGX
Protagonist Therapeutics, Inc
AwardDirect2.7K shares- - Jan 2, 2025PTGX
Protagonist Therapeutics, Inc
AwardDirect5.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 17, 2026 | PTGX Protagonist Therapeutics, Inc | Exercise | 18,000 | $10.84 | $195,120 | Direct |
| Feb 17, 2026 | PTGX Protagonist Therapeutics, Inc | Sale | 18,000 | $82.42 | $1,483,560 | Direct |
| Jan 2, 2026 | PTGX Protagonist Therapeutics, Inc | Award | 2,695 | - | $0 | Direct |
| Jan 2, 2025 | PTGX Protagonist Therapeutics, Inc | Award | 5,130 | - | $0 | Direct |
1-4 of 4 transactions